Many Americans living with HIV/AIDS receive critically important prescription drug coverage from state Medicaid programs. For these beneficiaries, Medicaid typically offers broad formularies, low cost sharing, and access to a large network of pharmacies.
However, about 50,000 to 60,000 persons with HIV/AIDS will be losing Medicaid drug coverage on January 1, 2006. These dual eligibles will required to enroll in the new Medicare prescription drug benefit (Medicare Part D). In Medicare D, these beneficiaries face more restrictive drug formularies, narrower pharmacy networks, the possibility of higher cost sharing, and private drug plans inexperienced the needs of large numbers of persons with life-threatening chronic conditions.
State AIDS Drug Assistance Programs (ADAPs) are another critically important lifeline for persons living with HIV and AIDS. ADAPs provide HIV/AIDS-related prescription drugs to about 30 percent of Americans with HIV/AIDS who are receiving care. Operating in every state with a mix of $1.2 billion in federal and state funding, each ADAP has different eligibility criteria. Drug formularies, also set by the states, vary widely.
The National ADAP Monitoring Project, an initiative of the Kaiser Family Foundation and the National Alliance of State and Territorial AIDS Directors, provides a wealth of useful information, including:
● Comprehensive annual report with the latest on state ADAPs. An executive summary is also available.
● Details on state HIV/AIDS drug formularies.
● State-level data on HIV/AIDS, spending, and programs.